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Abstract The male germ line stem cell is the only cell type in
the adult that can contribute genes to the next generation and is
characterized by postnatal proliferation. It has not been
determined whether this cell population can be used to
deliberately introduce genetic modification into the germ line to
generate transgenic animals or whether human somatic cell gene
therapy has the potential to accidentally introduce permanent
genetic changes into a patient’s germ line. Here we report that
several techniques can be used to achieve both in vitro and in vivo
gene transfer into mouse male germ line stem cells using a
retroviral vector. Expression of a retrovirally delivered reporter
lacZ transgene in male germ line stem cells and differentiated
germ cells persisted in the testis for more than 6 months. At least
one in 300 stem cells could be infected. The experiments
demonstrate a system to introduce genes directly into the male
germ line and also provide a method to address the potential of
human somatic cell gene therapy DNA constructs to enter a
patient’s germ line. ß 2000 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
Spermatogonial stem cells, the male germ line stem cells in
animals, divide throughout life. After puberty, they generate
large numbers of di¡erentiating spermatogonia that become
spermatocytes, which undergo meiotic recombination to gen-
erate genetic diversity. Spermatids are then formed, which
evolve into spermatozoa. Thus, stem cells are the foundation
for spermatogenesis and male reproduction. Attempts to in-
fect germ line stem cells with viral vectors or transfect them by
other techniques have met with little success. Despite a long
history of retroviral studies, there are no reports that show
direct infection of postnatal male germ line stem cells. In mice,
where retroviral infection of germ line stem cells is best char-
acterized, both male and female stem cells can be infected
before birth [1]. A series of classical studies in mice demon-
strated that germ line transmission was high when preimplan-
tation embryos were infected and very low (6 0.4%) when
postimplantation embryos were infected [2^4]. If newborn
mice were injected intraperitoneally with retroviruses, Leydig
cells were infected but not germ cells [5]. In sheep, it was
reported that no germ line transmission occurred when retro-
virus supernatant or producing cells were injected into em-
bryos in utero [6]. Use of other techniques to introduce genes
into male germ line stem cells has been limited. Recently, in
vivo whole-testis electroporation and lipofection by injecting
DNA construct into mouse seminiferous tubules were de-
scribed, but quantitative data on stable transfections into
stem cells were not provided [7^10]. Taken together, the re-
ports on infection by viral and transfection by non-viral tech-
niques suggest that delivery of genes to postnatal male germ
line stem cells is di⁄cult. However, postnatal stem cells can be
readily harvested compared to prenatal stem cells and contin-
ue to divide throughout life. Thus, they represent a unique
and valuable resource to modify the germ line in any species.
Recent development in the spermatogonial transplantation
technique now allows an accurate determination of the pres-
ence of stem cells and assessment of the e⁄ciency of various
gene delivery attempts into stem cells [11^13]. In this trans-
plantation system, a cell population containing putative sper-
matogonial stem cells is microinjected into the seminiferous
tubules of an infertile recipient mouse, in which only a stem
cell can generate a colony of spermatogenesis. Therefore, a
stem cell marked by expression of a reporter gene can be
unequivocally identi¢ed after transplantation. We used this
assay method combined with a replication-defective ecotropic
retroviral vector that contained the Escherichia coli lacZ struc-
tural gene, with the promoter of the phosphoglycerate kinase-
1 (Pgk) gene (Gen3PGKLgal) [14], to examine the potential of
several infection systems to introduce a new gene into sper-
matogonial stem cells of postnatal mice.
2. Materials and methods
2.1. Animals
Donor cells were obtained from two sources. Neonatal testis cells
were from C57BL/6U129/Sv (B6/129) F2 hybrid mice, 5^8 days of
age. Adult cells were from C57BL/6 (B6) males made cryptorchid at
6^8 weeks of age, by securing the testes inside the abdominal cavity
[15^17], and used 2 months later. Two types of recipient mice were
prepared. B6 mice made cryptorchid were used for the in vivo infec-
tion system, and B6/129 F1 hybrid males treated with busulfan to
destroy endogenous spermatogenesis were used for all other infection
systems [12]. Cell collection methods were as previously described [18^
20].
2.2. Cell infection and transplantation
Three di¡erent procedures were used for in vitro infection: feeder
infection, insert infection and periodic infection systems. For all in
vitro systems, donor cells were cultured at 37‡C at 2.2 þ 0.1U105 cells/
cm2 with 4 Wg/ml polybrene.
In the feeder infection system, donor testis cells were cultured on
Gen3PGKLgal virus-producing cells (105 cells/cm2 in 25 cm2 £asks),
which were mitotically arrested with mitomycin C. Medium was
changed and new feeder cells added on day 3. Cells were washed
with Dulbecco’s phosphate-bu¡ered saline (D-PBS), harvested and
transplanted into recipient testes on day 7.
In the insert infection system, donor testis cells were cultured on
mitomycin C-treated STO mouse embryonic ¢broblasts (5.2U104
cells/cm2 in 6-well plates). Gen3PGKLgal cells (8.6U104 cells/cm2)
were seeded on a permeable membrane in cell culture inserts (3 Wm
pore size); then the inserts were placed over the germ cell culture to
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separate virus-producing cells from germ cells. Medium and inserts
with virus-producing cells were changed on days 3 and 5. Inserts were
removed on day 7, cultures washed three times with D-PBS and in-
cubated for 20 h. On day 8, cultures were washed with D-PBS, har-
vested and transplanted into recipient testes.
In the periodic infection system, donor testis cells were cultured on
mitomycin C-treated STO cells (5.2U104 cells/cm2 in 25 cm2 £asks).
Two days later, the cells were fed with virus-containing medium for
2 h, then incubated with regular medium for 1 h. This cycle was
repeated 3^4 times a day for 6 days. Then the cells were washed
and harvested as in the insert system.
For in vivo luminal infection, a mixture of Gen3PGKLgal cells and
freshly collected testis cells (1:1) was injected into recipient testes.
Methods for cell culture and transplantation were as previously de-
scribed [18,20,21]. The retroviral vector (Gen3PGKLgal), based on
the Moloney murine leukemia virus, and its producer cell line (derived
from GP+E-86 packaging cells) were a generous gift of P. Soriano
and were maintained as described [14]. The original titer of
Gen3PGKLgal virus on Swiss 3T3 cells was 2.5 þ 0.4U105 colony
forming units (cfu)/ml.
3. Results and discussion
In preliminary experiments, we compared di¡erent tech-
niques to deliver a foreign gene to testis cells. For in vitro
gene delivery, we used lipofection and retrovirus infection,
and for in vivo gene delivery, whole-testis electroporation
[7^10]. Since only retrovirus infection resulted in unequivocal
introduction of a marker gene into spermatogonial stem cells,
we focused on this approach.
In our initial experiments, we microinjected Gen3PGKLgal
virus-producing cells into the seminiferous tubules of recipient
mice that were made cryptorchid by securing the testes inside
the abdominal cavity. After injection, the testes were returned
to the scrotum, anticipating that the in situ microenvironment
of seminiferous epithelium surrounding stem cells should fa-
cilitate continuing stem cell mitosis, a prerequisite for retro-
viral integration and expression. Cryptorchid testes are devoid
of the multiple layers of di¡erentiating germ cells, which are
characteristic of the normal tubular epithelium, and contain
only dividing primitive spermatogonia and Sertoli cells on the
basement membrane of the tubules [15^17]. Despite these sup-
posedly favorable characteristics, no colonies of spermatogen-
esis arising from transduced stem cells were found in the 14
testes injected (Table 1, line 1), apart from one recipient testis
containing a very small cluster of transduced spermatogonial-
type cells. However, this small cluster did not generate a blue
colony indicative of developing spermatogenesis. A potential
explanation for the inability of virus to infect spermatogonial
stem cells and generate colonies expressing the transgene is
that supporting somatic Sertoli cells cover and shield stem
cells from the virus present in the tubule lumen.
To determine if spermatogonial stem cells could be infected
when displaced from their protected niche in the tubule, we
employed three di¡erent in vitro systems: feeder infection,
insert infection and periodic infection (Fig. 1). These systems
were selected to maximize the titer of virus to which donor
cells were exposed and to vary conditions of infection. In the
feeder infection system, donor testis cells were cultured on
virus-producing feeder cells, and at the end of culture, donor
and feeder cells were transplanted together into recipient
testes. In the insert and periodic systems, donor testis cells
were cultured on STO feeder cells, and virus-producing cells
Fig. 1. Retroviral titers in mouse testis cell culture supernatants.
A: Feeder infection system. B: Insert infection system. C: Periodic
infection system. Viral titers in medium supernatant are indicated
by bars, and means during culture periods with viruses were:
A = 2.9 þ 0.5U104 ; B = 1.4 þ 0.3U104 ; C = 5.6 þ 0.6U104 cfu/ml.
Titers on day 8 were 55.1 þ 29.7 and 4.3 þ 0.9 cfu/ml for B and C,
respectively. All values are means þ S.E.M. for three or more deter-
minations.
Table 1
























In vivo ^ 7 ^ 12.9 þ 1.7 14 0 0 0
Feeder Neonate 11 8.7 þ 0.9 8.4 þ 0.9 28 13 20 8.5
Adult 10 6.5 þ 1.2 6.2 þ 1.0 36 6 9 4.0
Insert Neonate 9 10.9 þ 1.3 10.9 þ 1.0 43 3 3 0.6
Adult 5 9.6 þ 1.2 12.3 þ 1.5 35 5 6 1.4
Periodic Neonate 3 7.3 þ 1.1 7.8 þ 1.0 14 10 27 24.7
Adult 3 5.7 þ 0.3 5.8 þ 0.7 15 4 6 6.9
Control (insert) Adult 4 8.2 þ 1.2 4.4 þ 0.3 62 60 1068 391.5
Luminal Neonate 4 ^ 4.7 þ 0.3 23 16 42 38.9
Adult 4 ^ 5.0 þ 0.0 23 5 8 7.0
aMean þ S.E.M. Number of testis cells originally placed in culture per experiment.
bMean þ S.E.M. Number of cells injected was calculated based on the percent of recovered cells actually injected into a recipient testis times
the number of testis cells placed in culture (in vitro infections). All cells recovered or collected cannot be injected into a recipient testis because
the seminiferous tubule volume is limited. For in vivo infection, only Gen3PGKLgal virus-producing cells were injected into recipient seminifer-
ous tubules. For luminal infection, only the number of testis cells is shown.
cTestes were analyzed 2^3 months after cell transplantation. Di¡erentiation from primitive type A1 spermatogonia to spermatozoa takes 35
days in mice [24].
dTCE = (number of colonies)(107)/(number of cells injected per testis)(number of testes analyzed).
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were cultured separately from the testis cells (see Section 2). In
these two systems, the titer of virus particles associated with
testis cells at the time of transplantation was minimized by
washing the culture 1 day before transplantation and incubat-
ing the culture with fresh medium without the virus (Fig. 1).
Donor testis cells for infection were obtained from two sour-
ces. The ¢rst was neonatal testes, 5^8 days of age, at which
stage the stem cells are proliferating. In addition, neonatal
testes at this stage should be enriched for stem cells because
formation of di¡erentiating germ cells is just beginning. The
second source was adult experimental cryptorchid testes, in
which spermatogonia are actively dividing [15,17], and the
testis cell population is enriched for stem cells because di¡er-
entiating germ cells are destroyed by the high core body tem-
perature [16,22].
To determine the e⁄ciency of stem cell transduction by
retrovirus, both neonatal and cryptorchid testis cells were ex-
posed to virus using each of the three infection systems and
then transplanted into recipient mouse testes (Table 1). Two
to three months after transplantation, 171 recipient testes were
analyzed, and 71 blue areas representing colonies of spermato-
genesis originating from retrovirally transduced stem cells
were found (Table 1; Fig. 2). Spermatogenesis from donor
stem cells that are not infected with the retroviral vector or
in which the vector is not expressed will not produce blue-
stained cells. In addition, it is believed that each area of sper-
matogenesis generally represents colonization by the progeny
of one stem cell [12,13]. Therefore, at least 71 stem cells in-
tegrated and expressed the retroviral vector (Table 1, lines 2^
7). The transduction/colonization e⁄ciency (TCE) for the two
types of testis cells in the three infection systems varied, but
two patterns were observed (Table 1). First, periodic and in-
sert infections produced the highest and lowest TCE, respec-
tively. This could be due to di¡erences in viral titers in each
infection system (Fig. 1) or di¡erences in the ability of the
systems to support stem cells. Second, higher transduction
e⁄ciency was achieved with neonatal cells than with adult
cryptorchid cells in the periodic and feeder systems, but this
pattern was opposite in the insert system. Cells derived from
neonatal testes divide more rapidly than those from adult
cryptorchid testes. In addition, the insert system contains
more cells per cm2 culture surface than the periodic or feeder
systems. Therefore, there could be more rapid depletion of
nutrients in the neonatal insert compared to the adult cryp-
torchid insert culture environment, and poor stem cell survival
result in the former. The better results with neonatal cells in
periodic and feeder systems may re£ect a greater number of
stem cells in the original neonatal cell population, better stem
cell proliferation, or both.
Establishment of complete spermatogenesis by donor cells
(Fig. 2) can be achieved only from spermatogonial stem cells.
Therefore, these results clearly demonstrate that retroviral
vectors can be used to deliver genes into male germ line
stem cells of two di¡erent developmental ages (neonatal and
adult) with three separate systems. Since successful retroviral
infection with resultant gene expression requires cell division
for chromosomal integration of the viral genome, the present
results also indicate that the stem cells must be replicating in
vitro. Normal spermatogenesis with characteristic structural
morphology and mature spermatozoa were found in the
blue areas colonized by transduced stem cells (Fig. 2B^D).
Expression of the Pgk-lacZ transgene in areas of spermato-
genesis was present at least 6 months after transplantation,
and previous studies indicate that colonies arising from trans-
planted stem cells are permanent and produce spermatozoa
that transmit the donor haplotype to progeny [11,21,23].
The TCE represents the number of blue colonies produced
from 107 testis cells originally placed in culture and is a mea-
sure of the ability of each infection system to introduce a
foreign gene into stem cells (Table 1). However, the number
of stem cells actually present at any time in culture cannot be
determined because there are no morphological or biochem-
ical markers to identify the stem cells in vitro. Therefore, a
functional assay, such as testis cell transplantation, must be
used to identify stem cell activity. To estimate the number of
stem cells present at the end of culture, a control population
of cryptorchid testis cells from a transgenic mouse expressing
lacZ in male germ cells (C57BL/6J-Gtrosa26) was cultured
using the insert system with GP+E-86 packaging cells that
produced no virus. Then the total number of colonies gener-
ated by these cultures after transplantation was determined
Fig. 2. Spermatogenesis produced from stem cells into which a
transgene was introduced by retroviral infection during in vitro cul-
ture. Blue areas represent colonies of spermatogenesis arising from
donor stem cells transplanted to recipient testes, which were stained
to demonstrate expression of the viral transgene 2^6 months after
cell transplantation. A: Spermatogenic colony (blue) derived from
donor neonatal stem cells transduced in the periodic infection sys-
tem. Whole mount of testis was stained 6 months after cell trans-
plantation. B: Histological section of spermatogenic colony derived
from adult cryptorchid stem cells transduced with the insert infec-
tion system, analyzed 3 months after cell transplantation. Expression
of transgene indicated by blue staining is seen primarily in di¡eren-
tiated, late stages of spermatogenesis in this section. C: Histological
section of spermatogenic colony derived from neonatal stem cells
transduced by the periodic infection system, analyzed 3 months after
cell transplantation. Expression of transgene is present in germ cells
at all stages of di¡erentiation. Di¡erences in staining intensity and
pattern between B and C may re£ect the e¡ect on gene expression
of the integration site of virus and transgene in the stem cell chro-
mosome [2,25]. Similar di¡erences were observed among colonies
produced using each system. D: Higher magni¢cation of C. Pres-
ence of spermatozoa heads (arrows) and spermatozoa tails (arrow-
heads) indicates that complete spermatogenesis has been established
in the colony. Non-transduced transplanted stem cells also generate
complete spermatogenesis in recipient testes beginning at approxi-
mately 2 months after donor cell transplantation [12]. Stain: 5-bro-
mo-4-chloro-3-indolyl L-D-galactoside (X-gal), A^D; nuclear fast
red, B^D. Scale bars: A = 2 mm, B and C = 50 Wm, D = 20 Wm.
Testes of recipient mice were analyzed for transgene expression of
L-galactosidase by incubation with X-gal to produce blue staining
[11,12].
FEBS 23734 6-6-00 Cyaan Magenta Geel Zwart
M. Nagano et al./FEBS Letters 475 (2000) 7^10 9
(Table 1, line 8). This value is a measure of the number of
stem cells that survived conditions similar to those experi-
enced by cryptorchid cells infected using the insert system
(Table 1, line 5), and therefore is equivalent to 100% stem
cell TCE. Comparison of the TCE of adult cryptorchid cells
exposed to virus (1.4; Table 1, line 5) with the control TCE
(391.5; Table 1, line 8) indicates that about one in 280 stem
cells was infected and expressed the transgene using the insert
system.
On the basis of the above results, the ability to infect stem
cells in vivo was reexamined using a system in which freshly
collected testis cells and Gen3PGKLgal virus-producing cells
were coinjected into the seminiferous tubules of recipient mice
(luminal infection). As shown in Table 1, the luminal infection
resulted in a high TCE (Table 1; lines 9 and 10). However, a
major factor likely contributing to this transduction e⁄ciency
is the much greater number of stem cells present in freshly
collected donor cell populations without in vitro manipula-
tion. When 105 cryptorchid cells were injected into a recipient
testis immediately after collection, about 50 colonies were
formed [22], which translates into a control TCE of 5000.
This is a value more than 10 times greater than we found
for control adult cryptorchid testis cells after 1 week in culture
(391.5). Therefore, only about one in 714 (7.0/5000; Table 1,
line 10/control) stem cells appear to be infected with the viral
vector in the luminal system. Thus, while the absolute number
of stem cells infected is greater with the in vivo luminal sys-
tem, the e⁄ciency of infection of cryptorchid stem cells is
about 2.5 times (714/280) better with the in vitro insert sys-
tem.
Previous studies suggested that postnatal male germ line
stem cells were di⁄cult or impossible to transduce using viral
agents. However, the absence of a functional assay to directly
measure stem cell activity interfered with a conclusive deter-
mination. Although our initial studies with an in vivo infec-
tion approach agreed with published reports, the protection of
the stem cell in a niche surrounded by Sertoli and other so-
matic cells could explain the inability to detect infection. This
niche may o¡er a degree of protection for patients undergoing
somatic cell gene therapy. However, our studies indicate that
the potential exists for infection of the male germ line by viral
vectors. In addition, it is estimated that at least 4% of these
insertion sites will disrupt endogenous gene activity [4]. Using
several infection systems, which provided viral access to the
stem cell, we clearly established that viral transduction of
neonatal and adult spermatogonial stem cells can be achieved
at quite high levels in vitro and in vivo. Moreover, the use of
higher titer virus preparations available from other vector-
producing systems might allow greater levels of infection.
The present studies lay the groundwork for introduction of
new genes directly into the male germ line of many animal
species, and suggest that other transfection approaches should
be feasible when used with spermatogonial stem cell trans-
plantation.
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